Breast cancer biology and ethnic disparities in breast cancer mortality in New Zealand: A cohort study

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Seneviratne, Sanjeewa ^a   Lawrenson, Ross ^a   Scott, Nina ^b   Kim, Boa ^c   Shirley, Rachel ^c   Campbell, Ian ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b WAIKATO DISTRICT HEALTH BOARD   (New Zealand)

^c WAIKATO HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; ERBB2 PROTEIN, HUMAN; TUMOR MARKER;

ADVANCED CANCER; AGE; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER GRADING; CANCER MORTALITY; CANCER REGISTRY; CANCER SCREENING; CANCER STAGING; COHORT ANALYSIS; CONTROLLED STUDY; ETHNIC DIFFERENCE; ETHNIC GROUP; EUROPEAN; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NEW ZEALAND; NEW ZEALANDER; ONCOLOGICAL PARAMETERS; PRIMARY TUMOR; SOCIOECONOMICS; TUMOR INVASION; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; EARLY CANCER DIAGNOSIS; ENZYME IMMUNOASSAY; HEALTH CARE DISPARITY; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; REGISTER; RISK FACTOR; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE;

BIOMARKERS, TUMOR; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; COHORT STUDIES; EARLY DETECTION OF CANCER; ETHNIC GROUPS; FEMALE; HEALTHCARE DISPARITIES; HUMANS; IMMUNOENZYME TECHNIQUES; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEW ZEALAND; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REGISTRIES; RISK FACTORS; SURVIVAL RATE;

EID: 84927536737     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0123523     Document Type: Article

References (31)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010; 127(12):2893-917. doi: 10.1002/ijc.25516 PMID: 21351269
2. Althuis MD, Dozier JM, Anderson WF, Devesa SS, Brinton LA. Global trends in breast cancer incidence and mortality 1973-1997. Int J Epidemiol. 2005; 34(2):405-12. PMID: 15737977
3. Robson B, Purdie G, Cormack D. Unequal Impact II: Maori and Non-Maori Cancer Statistics by Deprivation and Rural-Urban Status 2002-2006. Wellington: Ministry of Health; 2010.
4. Ajwani S, Blakely T, Robson B, Tobias M, Bonne M. Decades of disparity: Ethnic mortality trends in New Zealand 1980-1999, Ministry of Health and University of Otago. Wellington, New Zealand 2003. PMID: 15475978
5. Cunningham R, Shaw C, Blakely T, Atkinson J, Sarfati D. Ethnic and socioeconomic trends in breast cancer incidence in New Zealand. BMC Cancer. 2010; 10:674. doi: 10.1186/1471-2407-10-674 PMID: 21138590
6. Ajwani S, Blakely T, Robson B, Tobias M, Bonne M. Decades of disparity: ethnic mortality trends in New Zealand 1980-1999. Ministry of Health and University of Otago, New Zealand; 2003. PMID: 15475978
7. Jeffreys M, Stevanovic V, Tobias M, Lewis C, Ellison-Loschmann L, Pearce N, et al. Ethnic inequalities in cancer survival in New Zealand: linkage study. Am J Public Health. 2005; 95(5):834-7. PMID: 15855462
8. Seneviratne S, Campbell I, Scott N, Coles C, Lawrenson R. Treatment delay for Maori women with breast cancer in New Zealand. Ethn Health. 2015; 20(2):178-93. doi: 10.1080/13557858.2014.895976 PMID: 24635721
9. Seneviratne S, Campbell I, Scott N, Kuper-Hommel M, Kim B, Pillai A, et al. Adherence to adjuvant endocrine therapy: Is it a factor for ethnic differences in breast cancer outcomes in New Zealand? The Breast. 2015; 24(1):62-7. doi: 10.1016/j.breast.2014.11.011 PMID: 25486877
10. Seneviratne S, Campbell I, Scott N, Kuper-Hommel M, Round G, Lawrenson R. Ethnic differences in timely adjuvant chemotherapy and radiation therapy for breast cancer in New Zealand: a cohort study. BMC Cancer. 2014; 14(1):839. doi: 10.1186/1471-2407-14-1 PMID: 24383403
11. Weston MK, Moss DP, Stewart J, Hill AG. Differences in breast cancer biological characteristics between ethnic groups in New Zealand. Breast Cancer Res Treat. 2008; 111(3):555-8. PMID: 18026873
12. Dachs GU, Kano M, Volkova E, Morrin HR, Davey VC, Harris GC, et al. A profile of prognostic and molecular factors in European and Maori breast cancer patients. BMC Cancer. 2010; 10:543. doi: 10.1186/1471-2407-10-543 PMID: 20932344
13. McKenzie F, Jeffreys M, Mannetje A, Pearce N. Prognostic factors in women with breast cancer: inequalities by ethnicity and socioeconomic position in New Zealand. Cancer Causes Control. 2008; 19(4):403-11. PMID: 18066672
14. Seneviratne S, Campbell I, Scott N, Shirley R, Peni T, Lawrenson R. Accuracy and completeness of the New Zealand Cancer Registry for staging of invasive breast cancer. Cancer Epidemiol. 2014; 38(5):638-44. doi: 10.1016/j.canep.2014.06.008 PMID: 25037979
15. Statistics New Zealand. 2006 Census Data 2007. Available: http://www.stats.govt.nz/.
16. Ministry of Health. Ethnicity Data Protocols for the Health and Disability Sector Wellington2004 [15/05/2014]. Available: http://www.health.govt.nz/publication/ethnicity-data-protocols-health-and-disability-sector.
17. Salmond C, Crampton P, Atkinson J. NZDep2006: Index of Deprivation. Wellington: Department of Public Health, University of Otago, Wellington., 2007.
18. American Joint Committee on Cancer. AJCC Cancer Staging Manual. New York: Springer-Verlag, 2010.
19. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991; 19(5):403-10. PMID: 1757079
20. Pauletti G, Godolphin W, Press MF, Slamon DJ. Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization. Oncogene. 1996; 13(1):63-72. E PMID: 8700555
21. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40(5):373-83. PMID: 3558716
22. O'Brien KM, Cole SR, Tse CK, Perou CM, Carey LA, Foulkes WD, et al. Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study. Clin Cancer Res. 2010; 16(24):6100-10. doi: 10.1158/1078-0432.CCR-10-1533 PMID: 21169259
23. Li CI, Malone KE, Daling JR. Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older. Cancer Epidemiol Biomarkers Prev. 2002; 11(7):601-7. PMID: 12101106
24. Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006; 295(21):2492-502. PMID: 16757721
25. Rosenberg J, Chia YL, Plevritis S. The effect of age, race, tumor size, tumor grade, and disease stage on invasive ductal breast cancer survival in the U.S. SEER database. Breast Cancer Res Treat. 2005; 89(1):47-54. PMID: 15666196
26. Jack RH, Davies EA, Renshaw C, Tutt A, Grocock MJ, Coupland VH, et al. Differences in breast cancer hormone receptor status in ethnic groups: a London population. Eur J Cancer. 2013; 49(3):696-702. doi: 10.1016/j.ejca.2012.09.012 PMID: 23058788
27. Vona-Davis L, Rose DP. The influence of socioeconomic disparities on breast cancer tumor biology and prognosis: a review. J Womens Health (Larchmt). 2009; 18(6):883-93. doi: 10.1089/jwh.2008.1127 PMID: 19514831
28. Taylor A, Cheng KK. Social deprivation and breast cancer. J Public Health Med. 2003; 25(3):228-33. PMID: 14575198
29. Haynes R, Pearce J, Barnett R. Cancer survival in New Zealand: ethnic, social and geographical inequalities. Soc Sci Med. 2008; 67(6):928-37. doi: 10.1016/j.socscimed.2008.05.005 PMID: 18573580
30. Salmond CE, Crampton P. Development of New Zealand's deprivation index (NZDep) and its uptake as a national policy tool. Can J Public Health. 2012; 103(8 Suppl 2):S7-11. PMID: 23618071
31. Allred DC. Commentary: hormone receptor testing in breast cancer: a distress signal from Canada. Oncologist. 2008; 13(11):1134-6. doi: 10.1634/theoncologist.2008-0184 PMID: 18987048